The YB1 Way of Surviving Radiation, Pediatric Brain Tumor Resistance and Recurrence |
Emory University / Abhinav Dey, PhD |
Young Investigator Grants |
2015 |
Georgia |
Characterization of the Role of Chromosome 1p Deletion in MYCN-Amplified Neuroblastoma |
University of California San Francisco / Miller Huang, PhD |
Young Investigator Grants |
2013 |
California |
Mechanisms of leukocyte recruitment to the lung during idiopathic pneumonia syndrome following allogeneic bone marrow transplantation.
|
Regents of the University of Michigan / Sung Won Choi, MD |
Young Investigator Grants |
2006 |
Michigan |
Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma |
Dana-Farber Cancer Institute / David Debruyne, PhD |
Young Investigator Grants |
2016 |
Massachusetts |
Validation of microRNAs as valid targets in a pediatric sarcoma |
University of Texas Southwestern Medical Center / Mark Hatley |
Young Investigator Grants |
2011 |
Texas |
The Role of PARP3 in the Formation of Chromosomal Translocations |
Dana-Farber Cancer Institute / Tovah Day, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Genetic Dissection of Trisomy 21-TMD Using Human Pluripotent Stem Cells |
Boston Children’s Hospital / Glenn MacLean |
Young Investigator Grants |
2013 |
Massachusetts |
Molecular Mechanism and Development of Therapeutic Strategies Targeting MYCN-induced Calcium Signaling in Advanced Neuroblastoma |
University of Hawaii at Hilo / Ingo Koomoa-Lange, PhD |
Young Investigator Grants |
2014 |
Hawaii |
Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD |
Young Investigator Grants |
2012 |
Washington |
Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma |
University of California San Francisco / Zhenyi An, PhD |
Young Investigator Grants |
2015 |
California |